Skip to content

Indivior Pharmaceuticals, Inc. INDV Gain (loss) on extinguishment of debt

Gain (loss) on extinguishment of debt at other companies

Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$1.8M
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
-$372K
Scholar Rock logo
Scholar RockSRRK
-$3.34M
Solaris Energy Infrastructure logo
Solaris Energy InfrastructureSEI
-$1.26M
AVT
AvantorAVTR
-$600K
Healthcare Realty Trust logo
Healthcare Realty TrustHR
-$21K

Segments

By segment

See full
Reportable Segment-$18M

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's gain (loss) on extinguishment of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's gain (loss) on extinguishment of debt?
Indivior Pharmaceuticals, Inc. (INDV) reported gain (loss) on extinguishment of debt of -$18M in Q1 2026.
What does gain (loss) on extinguishment of debt mean?
Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.